Peritoneal Transport Characteristics Among Pakistani Patients Undergoing Peritoneal Dialysis
Peritoneal Transport Characteristics Among Pakistani Patients Undergoing Peritoneal Dialysis
DOI:
https://doi.org/10.53778/pjkd101346Keywords:
peritoneal dialysis, peritoneal dialysis equilibration test, adequacy, Kt/V, End stage Kidney disease, residual renal functionAbstract
Background: The peritoneal membrane acts as a biological filter to remove solutes and fluids during peritoneal dialysis, a well-known kind of renal replacement treatment. Dialysis prescriptions and clinical results are directly influenced by the four transport categories that the peritoneal equilibration test assigns to patients: low, low-average, high-average, and high. The published literature still lacks population-specific transport data from Pakistan.
Objective: To determine the distribution of peritoneal transport types among Pakistani patients undergoing peritoneal dialysis and to evaluate the demographic, clinical, and biochemical variables associated with transport status.
Materials and Methods: Four tertiary care hospitals in Lahore participated in a multicenter, cross-sectional, observational study. One hundred adult patients receiving continuous ambulatory peritoneal dialysis underwent a standard peritoneal equilibration test six weeks after dialysis began. Transport categorization was done using the Twardowski criterion and the 4-hour dialysate-to-plasma creatinine ratio.
Results: High-average and high transporters collectively constituted 77% of the study population (57% and 20%, respectively). Older age (p = 0.02), lower body mass index (p = 0.02), diabetic nephropathy (p = 0.03), hypoalbuminemia (p < 0.001), raised C-reactive protein (p < 0.001), and decreased net ultrafiltration volume (p < 0.001) were all substantially correlated with higher transport status.
Conclusion: A marked predominance of high peritoneal transport phenotypes was identified in this Pakistani population, attributed to the compounding influence of diabetic nephropathy, systemic inflammation, and nutritional deficits. These findings underscore the need for transport-guided dialysis prescription in this clinical setting.
References
Ying M, Shao X, Qin H, Yin P, Lin Y, Wu J, et al. Disease burden and epidemiological trends of chronic kidney disease at the global, regional, national levels from 1990 to 2019. Nephron. 2024;148(2):113–123. doi:10.1159/000534071.
Deng L, Guo S, Liu Y, Zhou Y, Liu Y, Zheng X, et al. Global, regional, and national burden of chronic kidney disease and its underlying etiologies from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021. BMC Public Health. 2025;25:636. doi:10.1186/s12889-025-21851-z.
Iqbal H, Abbas SW, Rasheed A, Rehman MFU, Asad M, Saeed HA, Jamil I. Frequency of diabetic nephropathy among patients of type 2 diabetes mellitus. Pak Armed Forces Med J. 2025;75(6):1094–1099. doi:10.51253/pafmj.v75i6.10339.
Teitelbaum I, Burkart J. Peritoneal dialysis. Am J Kidney Dis. 2003;42(5):1082–1096. doi:10.1016/j.ajkd.2003.08.036.
AlRashed H, Miele J, Prasad J, Adenikinju D, Iloegbu C, Patena J, et al. Systematic review of end stage renal disease in Pakistan: identifying implementation research outcomes. PLoS One. 2023;18(12):e0296243. doi:10.1371/journal.pone.0296243.
Azam R, Raza M. The potential of peritoneal dialysis as a cost-effective and sustainable treatment option for chronic kidney disease: a perspective from a resource-limited country like Pakistan. Pak J Med Sci. 2023;39(6):1898. doi:10.12669/pjms.39.6.8560.
Gu J, Bai E, Ge C, Winograd J, Shah AD. Peritoneal equilibration testing: your questions answered. Perit Dial Int. 2023;43(5):361–373. doi:10.1177/08968608221133629.
Morelle J, Stachowska-Pietka J, Öberg C, Gadola L, La Milia V, Yu Z, et al. ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: classification, measurement, interpretation and rationale for intervention. Perit Dial Int. 2021;41(4):352–372. doi:10.1177/0896860820982218.
Chou YH, Chen YT, Chen JY, Tarng DC, Lin CC, Li SY. Baseline peritoneal membrane transport characteristics are associated with peritonitis risk in incident peritoneal dialysis patients. Membranes (Basel). 2022;12(3):276. doi:10.3390/membranes12030276.
Kaouiri Z, Assem M, Sakout N, Bouattar T, Ouzeddoun N, Benamar L. Optimizing peritoneal dialysis with peritoneal equilibration test: membrane characterization to tailored therapy. Indian J Nephrol. 2025;0:1–5. doi:10.25259/IJN_687_2024.
Paudel K, Qayyum A, Wazil AWM, Sharma SK, Shrestha K, Fan S, et al. Overcoming barriers and building a strong peritoneal dialysis programme: experience from three South Asian countries. Perit Dial Int. 2021;41(5):480–483. doi:10.1177/08968608211019986.
Uncanin S, Serdarevic N, Klapuh N, Haskovic E. Peritoneal transport characteristics at the beginning and in long term peritoneal dialysis: a single center experience. Mater Sociomed. 2020;32(2):99–104. doi:10.5455/msm.2020.32.99-104.
Fajardo-Leitzelar FA, Sierra M, Barahona-López DM, Sánchez-Sierra LE, Matute-Martinez CF, Mendoza-Sabillón DE, et al. Análisis de pacientes en diálisis peritoneal: factores clínico-epidemiológicos y tipo de transporte peritoneal con recambio hipertónico. Rev Colomb Nefrol. 2018;5(2):146–155. doi:Not provided.
Xu L, Qian Y, Song Q, Yan H, Yu Z, Li Z, et al. Impact of diabetes on survival and clinical outcomes in elderly patients receiving peritoneal dialysis. Ren Fail. 2025;47(1):2589586. doi:10.1080/0886022X.2025.2589586.
Khachroumi N, Boyer A, Lanot A, Ficheux M, Bechade C, Lobbedez T. Outcomes of diabetic patients undergoing peritoneal dialysis in the French Language Peritoneal Dialysis Registry. Clin Kidney J. 2026;19(1):sfaf382. doi:10.1093/ckj/sfaf382.
Margetts PJ, McMullin JP, Rabbat CG, Churchill DN. Peritoneal membrane transport and hypoalbuminemia: cause or effect? Perit Dial Int. 2000;20(1):14–18. doi:10.1177/089686080002000104.
AlMojalled RM, Almabadi RM, Alghamdi AA, Alnugali RZ. Correlation of serum albumin levels with laboratory parameters in automated peritoneal dialysis and continuous ambulatory peritoneal dialysis patients: a prospective study. Cureus. 2023;15(10):e47364. doi:10.7759/cureus.47364.
Rodríguez-García VH, López-Guerra EA, Rodríguez-Castellanos FE. Association between peritoneal protein excretion, peritonitis and D/P phosphate in patients on peritoneal dialysis. Nefrologia. 2013;33(2):204–213. doi:10.3265/Nefrologia.pre2012.Oct.11651.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Muhammad Irfan Jamil, ROSHINA ANJUM, AHAD QAYYUM, Muhammad Mohsin Riaz, Uzair Ahmed , Fatima Saleemi, MUHAMMAD BILAL BASIT

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
